JenaValve Technology is a medical device company that develops and manufactures transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease. The company's products are designed to be minimally invasive and provide a safe and effective alternative to traditional open-heart surgery. JenaValve's TAVI systems are based on a proprietary design that allows for precise positioning and deployment of the valve, while also reducing the risk of complications. The company was founded in 2006 and is headquartered in Munich, Germany.